Congenital Insensitivity to Pain and Anhidrosis (CIPA): Difference between revisions

(Created blank page)
 
No edit summary
Line 1: Line 1:
== Introduction ==
Congenital Insensitivity to Pain and Anhidrosis (CIPA) is a rare genetic disorder affecting the autonomic nervous system and is described as hereditary sensory and autonomic neuropathy type IV (HSAN IV). It is characterized by the inability to perceive pain and temperatures sensations and the inability to sweat<ref>Axelrod FB, Gold-von Simson G. Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet journal of rare diseases. 2007 Dec;2(1):1-2.</ref>. It's incidence varies among populations but is estimated to occur in 1 in 125 million newborns<ref>Daneshjou K, Jafarieh H, Raaeskarami SR. Congenital insensitivity to pain and anhydrosis (CIPA) syndrome; a report of 4 cases. Iranian journal of pediatrics. 2012 Sep;22(3):412.</ref>.


== Reference ==

Revision as of 13:20, 23 September 2023

Introduction[edit | edit source]

Congenital Insensitivity to Pain and Anhidrosis (CIPA) is a rare genetic disorder affecting the autonomic nervous system and is described as hereditary sensory and autonomic neuropathy type IV (HSAN IV). It is characterized by the inability to perceive pain and temperatures sensations and the inability to sweat[1]. It's incidence varies among populations but is estimated to occur in 1 in 125 million newborns[2].

Reference[edit | edit source]

  1. Axelrod FB, Gold-von Simson G. Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet journal of rare diseases. 2007 Dec;2(1):1-2.
  2. Daneshjou K, Jafarieh H, Raaeskarami SR. Congenital insensitivity to pain and anhydrosis (CIPA) syndrome; a report of 4 cases. Iranian journal of pediatrics. 2012 Sep;22(3):412.